Scarica l'app Stockscreener
290.06
0.44%
1.27
Dopo l'orario di chiusura:
250.00
-40.06
-13.81%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Illumina Inc Borsa (ILMN) Ultime notizie
Thailand Next Generation Sequencing (NGS) Market Size, Share, Trends, and Forecast2026 to 2036 | Precision Medicine Drives 12.7% CAGR and a $305.21 Million Opportunity - GlobeNewswire Inc.
Which Biotech ETF Is the Better Buy: VanEck’s BBH or Invesco’s Factor-Driven PBE? - The Motley Fool
Billionaire Investor Adds to Danaher Stake After Cutting It Earlier This Year - TradingView
VanEck Biotech vs. Invesco Healthcare: Which ETF Offers More Potential for Long-Term Growth? - The Motley Fool
Illumina downgraded by Stephens with a new price target - Quantisnow
Should Illumina Stock Holders Look At Thermo Fisher Instead? - Trefis
Here’s How Much You Would Have Made Owning Illumina Stock In The Last 20 Years - Benzinga
Illumina, Inc. Estimates – NASDAQ:ILMN - TradingView
Illumina stock may move 9.3% on earnings release - Investing.com
Illumina: NovaSeq X And Consumables Sustain Momentum (NASDAQ:ILMN) - Seeking Alpha
Illumina (ILMN) Reports Next Week: Wall Street Expects Earnings Growth - Zacks Investment Research
Illumina (ILMN) Reports Next Week: Wall Street Expects Earnings Growth - Yahoo Finance
ILMN Q3 Earnings Preview: Strong Clinical Demand May Lift Performance - TradingView
Illumina's Stock Has Run Ahead Of Its Q3 Step-Down, Raising The Stakes On Clinical Demand - Finviz
Illumina Jumps 5.4% Amid Sector-Wide Rally - AlphaStreet
Illumina Inc. stock outperforms competitors on strong trading day - MarketWatch
Illumina’s (ILMN) Strong Quarterly Beats on Revenue and Earnings Drive Share Gains - Yahoo Finance
Illumina BioInsight Platform expands with new software to accelerate the path from sequencing to discovery - Illumina
Illumina BioInsight Platform expands with new software to accelerate the path from sequencing to discovery - PR Newswire
Illumina, Inc. (ILMN) Launches Early-Access AI Genomics Tools - TradingView
How to Find Strong Medical Stocks Slated for Positive Earnings Surprises - Zacks Investment Research
Single Cell Sequencing Market Forecast to 2035: Services, Technologies, End-users, Applications, and Regions | 15% CAGR Drives Drug Discovery and Precision Medicine Growth - GlobeNewswire Inc.
Will Illumina (ILMN) Beat Estimates Again in Its Next Earnings Report? - Yahoo Finance
Will Illumina (ILMN) Beat Estimates Again in Its Next Earnings Report? - Zacks Investment Research
In Brief This Week: Illumina, Interpace, Ocugen, Roots, Elicera, Verily, Quantum-Si, More - GenomeWeb
Illumina, Inc. (ILMN) Options Chain - Yahoo! Finance Canada
Illumina Inc. stock underperforms Thursday when compared to competitors - MarketWatch
TD Cowen lifts target for Illumina stock to USD 270.00 - ad-hoc-news.de
Saudi Arabia Non-Invasive Prenatal Testing Market 2026-2034: Executive Report | NGS Adoption and Healthcare Investment Drive 13.35% CAGR Toward US$162.16 Million - GlobeNewswire Inc.
$100 Invested In Illumina 15 Years Ago Would Be Worth This Much Today - Benzinga
Illumina 5-Base DNA Prep with Enzymatic Fragmentation - Illumina
Illumina Debuts BioInsight Platform, Expands AI Tools for Genomic Research - marketscreener.com
Illumina Consolidates Data Analysis Products Into New Platform, Pricing Model - GenomeWeb
Press Release - Illumina
Illumina launches BioInsight Platform, its first unified software environment to help accelerate genomic and multiomic breakthroughs - PR Newswire
Illumina, Inc. (ILMN) Launches BioInsight Platform With DRAGEN v4.6 - TradingView
Is Invesco Biotechnology & Genome ETF (PBE) a Strong ETF Right Now? - Zacks Investment Research
Did Illumina’s (ILMN) New SpliceAI2 Genomic Model Just Reframe Its Clinical Genomics Narrative? - Yahoo Finance
Illumina Launches $1.0 Billion Unsecured Commercial Paper Program; Signs Dealer Agreements - TradingView
Illumina Inc. stock underperforms Tuesday when compared to competitors - MarketWatch
Illumina Earnings Preview: What to Expect - Barchart.com
Should Invesco S&P MidCap Quality ETF (XMHQ) Be on Your Investing Radar? - Zacks Investment Research
Illumina’s (ILMN) Sequencing Business Is Recovering, But Is the Stock Getting Ahead of Itself? - Yahoo Finance
Introducing SpliceAI2: The Next Generation of Splicing and Transcript Isoform Prediction - Illumina
Illumina Inc (ILMN) Stock Up 5.1% but GF Value Says Overvalued -- GF Score: 65/100 - GuruFocus
Illumina Inc. stock outperforms competitors on strong trading day - MarketWatch
Illumina, Inc. Stock 12‑Month Price Target Raised to $237.16, Implies 10% Downside - TradingView
What is Illumina’s (ILMN) Economic Moat, and is it Widening or Narrowing? - Yahoo Finance
Illumina to Announce Third Quarter 2026 Financial Results on Thursday, October 29, 2026 - Investing News Network
Illumina, Inc. Initiates Recall of NovaSeq 6000Dx Including DRAGEN Server And Illumina DRAGEN Server For NextSeq 550Dx - www.marketscreener.com
1.43%
2.32%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):